Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
about
Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical Trial.R1 autonomic nervous system in acute kidney injury.Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.Intensive care medicine in 2050: vasopressors in sepsis.Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study.Effect of norepinephrine dosage on mortality in patients with septic shock.
P2860
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@en
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@nl
type
label
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@en
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@nl
prefLabel
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@en
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@nl
P2093
P2860
P1476
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
@en
P2093
Johannes G van der Hoeven
Matthijs Kox
Peter Pickkers
Roeland F Stolk
P2860
P304
P356
10.1164/RCCM.201604-0862CP
P407
P577
2016-07-11T00:00:00Z